180 related articles for article (PubMed ID: 29129987)
1. Increasing the Fungicidal Action of Amphotericin B by Inhibiting the Nitric Oxide-Dependent Tolerance Pathway.
Vriens K; Kumar PT; Struyfs C; Cools TL; Spincemaille P; Kokalj T; Sampaio-Marques B; Ludovico P; Lammertyn J; Cammue BPA; Thevissen K
Oxid Med Cell Longev; 2017; 2017():4064628. PubMed ID: 29129987
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence studies on the molecular action of amphotericin B on susceptible and resistant fungal cells.
Haynes MP; Chong PL; Buckley HR; Pieringer RA
Biochemistry; 1996 Jun; 35(24):7983-92. PubMed ID: 8672502
[TBL] [Abstract][Full Text] [Related]
3. ROS formation is a differential contributory factor to the fungicidal action of Amphotericin B and Micafungin in Candida albicans.
Guirao-Abad JP; Sánchez-Fresneda R; Alburquerque B; Hernández JA; Argüelles JC
Int J Med Microbiol; 2017 Jun; 307(4-5):241-248. PubMed ID: 28412040
[TBL] [Abstract][Full Text] [Related]
4. Enhancement effect of N-methyl-N″-dodecylguanidine on the vacuole-targeting fungicidal activity of amphotericin B against the pathogenic fungus Candida albicans.
Yutani M; Ogita A; Usuki Y; Fujita K; Tanaka T
J Antibiot (Tokyo); 2011 Jul; 64(7):469-74. PubMed ID: 21522157
[TBL] [Abstract][Full Text] [Related]
5. A common mechanism involving the TORC1 pathway can lead to amphotericin B-persistence in biofilm and planktonic Saccharomyces cerevisiae populations.
Bojsen R; Regenberg B; Gresham D; Folkesson A
Sci Rep; 2016 Feb; 6():21874. PubMed ID: 26903175
[TBL] [Abstract][Full Text] [Related]
6. Dependence of vacuole disruption and independence of potassium ion efflux in fungicidal activity induced by combination of amphotericin B and allicin against Saccharomyces cerevisiae.
Ogita A; Yutani M; Fujita K; Tanaka T
J Antibiot (Tokyo); 2010 Dec; 63(12):689-92. PubMed ID: 20940723
[TBL] [Abstract][Full Text] [Related]
7. Enhancing the fungicidal activity of amphotericin B via vacuole disruption by benzyl isothiocyanate, a cruciferous plant constituent.
Yamada N; Murata W; Yamaguchi Y; Fujita KI; Ogita A; Tanaka T
Lett Appl Microbiol; 2021 Apr; 72(4):390-398. PubMed ID: 33128810
[TBL] [Abstract][Full Text] [Related]
8. Amphotericin B induces trehalose synthesis and simultaneously activates an antioxidant enzymatic response in Candida albicans.
González-Párraga P; Sánchez-Fresneda R; Zaragoza O; Argüelles JC
Biochim Biophys Acta; 2011 Aug; 1810(8):777-83. PubMed ID: 21570449
[TBL] [Abstract][Full Text] [Related]
9. Amphotericin B-copper(II) complex shows improved therapeutic index in vitro.
Chudzik B; Czernel G; Miaskowski A; Gagoś M
Eur J Pharm Sci; 2017 Jan; 97():9-21. PubMed ID: 27816628
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of the fungicidal activity of amphotericin B by allicin, an allyl-sulfur compound from garlic, against the yeast Saccharomyces cerevisiae as a model system.
Ogita A; Fujita K; Taniguchi M; Tanaka T
Planta Med; 2006 Oct; 72(13):1247-50. PubMed ID: 16902870
[TBL] [Abstract][Full Text] [Related]
11. Linolenic acid-modified methoxy poly (ethylene glycol)-oligochitosan conjugate micelles for encapsulation of amphotericin B.
Song Z; Wen Y; Deng P; Teng F; Zhou F; Xu H; Feng S; Zhu L; Feng R
Carbohydr Polym; 2019 Feb; 205():571-580. PubMed ID: 30446143
[TBL] [Abstract][Full Text] [Related]
12. The mechanism of overcoming multidrug resistance (MDR) of fungi by amphotericin B and its derivatives.
Slisz M; Cybulska B; Grzybowska J; Czub J; Prasad R; Borowski E
J Antibiot (Tokyo); 2007 Jul; 60(7):436-46. PubMed ID: 17721002
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata.
Barchiesi F; Spreghini E; Tomassetti S; Arzeni D; Giannini D; Scalise G
Antimicrob Agents Chemother; 2005 Dec; 49(12):4989-92. PubMed ID: 16304162
[TBL] [Abstract][Full Text] [Related]
14. Combination of baicalein and Amphotericin B accelerates Candida albicans apoptosis.
Fu Z; Lu H; Zhu Z; Yan L; Jiang Y; Cao Y
Biol Pharm Bull; 2011; 34(2):214-8. PubMed ID: 21415530
[TBL] [Abstract][Full Text] [Related]
15. The vacuole-targeting fungicidal activity of amphotericin B against the pathogenic fungus Candida albicans and its enhancement by allicin.
Borjihan H; Ogita A; Fujita K; Hirasawa E; Tanaka T
J Antibiot (Tokyo); 2009 Dec; 62(12):691-7. PubMed ID: 19876074
[TBL] [Abstract][Full Text] [Related]
16. Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans.
An M; Shen H; Cao Y; Zhang J; Cai Y; Wang R; Jiang Y
Int J Antimicrob Agents; 2009 Mar; 33(3):258-63. PubMed ID: 19095412
[TBL] [Abstract][Full Text] [Related]
17. Amphotericin B-copper(II) complex as a potential agent with higher antifungal activity against Candida albicans.
Chudzik B; Tracz IB; Czernel G; Fiołka MJ; Borsuk G; Gagoś M
Eur J Pharm Sci; 2013 Aug; 49(5):850-7. PubMed ID: 23791641
[TBL] [Abstract][Full Text] [Related]
18. Lysine enhances the effect of amphotericin B against Candida albicans in vitro.
Zhao L; Jiang J; Zhu Z; Liao Z; Yao X; Yang Y; Cao Y; Jiang Y
Acta Biochim Biophys Sin (Shanghai); 2016 Feb; 48(2):182-93. PubMed ID: 26711896
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro antifungal susceptibility activity of amphotericin B versus amphotericin B methyl ester against Candida albicans ocular isolates.
Thanathanee O; Miller D; Ringel DM; Schaffner CP; Alfonso EC; O'Brien TP
J Ocul Pharmacol Ther; 2012 Dec; 28(6):589-92. PubMed ID: 22788845
[TBL] [Abstract][Full Text] [Related]
20. Biliary amphotericin B pharmacokinetics and pharmacodynamics in critically ill liver transplant recipients receiving treatment with amphotericin B lipid formulations.
Welte R; Eschertzhuber S; Weiler S; Leitner-Rupprich S; Aigner M; Lass-Flörl C; Stienecke E; Bellmann-Weiler R; Joannidis M; Bellmann R
Int J Antimicrob Agents; 2015 Sep; 46(3):325-31. PubMed ID: 26119497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
